Amprosid

Quick links to important sections

Amprosid

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amprosid

What is Amprosid? Defining its Core Identity and Class

Property Description
Active ingredient Amprolium hydrochloride (INN)
Form Water-soluble powder, Oral solution, Feed premix
Pharmacological class Coccidiostat, Antiprotozoal
Common use Control and management of Coccidiosis in animals
Origin Synthetic (Thiamine analogue)

Amprosid is a specialized veterinary pharmaceutical preparation whose active ingredient is the International Nonproprietary Name (INN) Amprolium. This compound is classified as a potent coccidiostat and antiprotozoal agent, primarily intended for the management of the parasitic disease coccidiosis caused by Eimeria species in susceptible animal populations, such as poultry and calves. Amprolium is an effective agent for the treatment and prophylaxis of coccidiosis in poultry and other animals, characterized by its activity against the parasitic infection. This efficacy positions the medicine as a tool for controlling the parasitic burden in these populations, a benefit recognized within veterinary pharmacology.

Amprolium: Origin, Composition, and Available Forms

Amprolium hydrochloride, the key component, is a synthetic compound chemically identified as an organic chloride salt and a pyridinium salt. Its molecular structure closely resembles Vitamin B1 (Thiamine), a distinguishing characteristic that defines its specific mode of action. Amprosid is produced as a single active ingredient product, commonly supplied as a highly concentrated water-soluble powder or an oral solution tailored for mass administration. Specialized formulations designated as a feed premix utilize an inert carrier base, allowing for seamless incorporation into livestock feed. The primary route of administration is oral, allowing for delivery throughout a targeted animal group.

How Amprolium Works: The Principle of Competitive Antagonism

Amprolium functions through a specific mechanism based on its identity as a thiamine analogue. The drug acts as a competitive antagonist, effectively blocking the thiamine transporter system required by the Eimeria parasite. This strategic interference causes competitive inhibition. This process prevents the uptake of the essential vitamin, vital for the parasite’s carbohydrate metabolism, thereby disrupting its reproductive cycle and controlling the parasitic load within the host.

What side effects are possible with Amprosid?

Possible Side Effects and Safety Information

The official regulatory safety data for Amprosid (Amprolium hydrochloride), a veterinary medication, primarily addresses risks associated with misuse and specific populations, as adverse events are generally not known when the product is used within approved therapeutic ranges in the target animal species (e.g., chickens and turkeys).

Officially Documented Adverse Reactions

The most serious safety concern documented in regulatory texts is Thiamine Deficiency (Vitamin B1 deficiency). This effect is specifically linked to prolonged use at high doses or overdose, which is a consequence of the drug's mechanism as a thiamine analogue.

In such cases of overdose, the deficiency can affect the Nutritional/Metabolic system and, consequently, the Nervous System, potentially leading to severe neurological manifestations such as ataxia (incoordination) and tremors.

Safety Considerations for Specific Populations

Official labeling includes constraints regarding specific animal groups:

  • Laying Birds: Safety is not established for birds producing eggs for human consumption. Use requires a formal benefit/risk assessment by a veterinarian.
  • Pre-ruminating Calves: A mandatory withdrawal period has not been established for all authorized formulations in this group.

Regulatory Safety Restrictions

Official documents define high-level safety limitations and required handling notes:

  • Drug Incompatibilities: The product must not be mixed with other veterinary medicinal products without confirmation of compatibility.
  • Reduced Efficacy Risk: Concurrent use with certain Vitamin B-Complex products may reduce the medication's intended efficacy.
  • Human Handling: The active ingredient is classified as a potential respiratory and skin sensitizer and irritant, requiring handlers to observe specific safety precautions during administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation classifies the adverse effects and toxicity risks of Amprosid (Amprolium hydrochloride) strictly based on documented clinical and physiological findings. The primary manifestation associated with overdose or prolonged, high-level exposure is the induction of thiamine deficiency, resulting from the drug's activity as a thiamine analogue. This deficiency is the root cause of the toxicity described in regulatory documents.

Severe Outcomes and Management

Regulatory-aligned toxicology data documents the potential for severe or life-threatening outcomes in situations where the margin of error is exceeded. These outcomes include the risk of hemorrhagic diathesis and, ultimately, death.

In terms of management, the official supportive measure described is thiamine supplementation. This is specified as the means to compensate for the deficiency if symptoms appear.

Required Emergency Action

Official instructions mandate specific actions for accidental exposure by the person administering the product. If accidental ingestion (by humans) occurs, the exposed individual must seek medical advice immediately. This immediate action is required regardless of symptom presence. Regulatory guidance further mandates that the individual show the product label or leaflet to the treating physician.

Therapeutic Uses of Amprosid

Quick Facts: Amprosid Uses

  • Target Condition: Coccidiosis
  • Primary Role: Treatment and prevention of certain outbreaks
  • Approved Species: Growing chickens, turkeys, and laying hens; beef and dairy calves

Amprosid is an agent used in the management of coccidiosis, an intestinal condition that can affect poultry and calves. The medication is indicated for the treatment of outbreaks of this condition in growing chickens, turkeys, and laying hens. It is also approved for use as an aid in the treatment and prevention of coccidiosis caused by Eimeria bovis and Eimeria zurnii in beef and dairy calves.

Its function is to help disrupt the lifecycle of the organisms that contribute to coccidiosis, working within the host's intestinal environment. This role supports the control of the condition within the affected animals.

Amprosid is also used in the prevention of certain coccidiosis outbreaks in various species of poultry and is intended to support the development of active immunity in replacement chickens.

Regulatory References

  1. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3943

Eligibility and Restrictions for Use

Who Can and Cannot Use Amprosid?

Eligibility for Amprosid (Amprolium hydrochloride) is strictly defined by regulatory documents, focusing on approved animal species and specific agricultural restrictions related to food safety. Amprosid is a veterinary pharmaceutical; therefore, all eligibility rules apply to animal populations, not human patients.

Official Eligibility and Restrictions

Category Eligible Populations Restrictions & Contraindications
Approved Species Growing Chickens, Turkeys, Laying Hens Must not be used in animals not listed as approved species.
Bovine Use Beef Calves, Dairy Calves Restricted to use as an aid in treating and preventing coccidiosis caused by Eimeria bovis and E. zurnii.
Food Safety Replacement Chickens Contraindicated in poultry producing eggs for human consumption. Not permitted for calves intended for veal processing.

Eligibility is defined by the animal's life stage, such as "Growing Chickens" or "Calves," rather than specific age thresholds. The official label imposes absolute prohibitions on populations that would introduce the drug into the human food supply chain via specific products, ensuring compliance with required food safety standards.

What should I know about interactions with other medicines?

Amprosid Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Amprosid (Amprolium hydrochloride) as specified in government regulatory documents. The product’s interaction profile is defined by specific administration constraints and pharmacodynamic effects arising from co-administration.


Official Interacting Substances and Restrictions

Interacting Substance/Product Documented Interaction Outcome or Restriction Regulatory Basis
Products containing Vitamin B-complex Co-administration may reduce the efficacy of Amprolium. This is classified as a pharmacodynamic interaction related to the drug’s structure as a thiamine analogue. Efficacy-altering interaction
Bentonite (in feed) Strict Prohibition: The product must not be used in feeds containing bentonite. Formal use restriction
Other veterinary medicinal products Major Incompatibility: Must not be mixed with any other veterinary medicinal products in the absence of documented compatibility studies. Administration constraint

Resulting Interaction Structure

The regulatory information establishes three key constraints for Amprosid. The most definitive restriction is the prohibition against co-administration with bentonite in feed. Furthermore, the product has a stated major incompatibility, meaning it must not be mixed with other veterinary solutions. The profile is completed by the pharmacodynamic interaction noting that simultaneous use of Vitamin B-complex products may result in a reduction of Amprolium’s intended efficacy. No systemic pharmacokinetic or transporter-mediated interactions are formally documented in the official regulatory prescribing information.

Mechanism of Action

️ How Amprosid Works: The Mechanistic Principle

Amprosid's activity is governed by its unique function as a metabolic antagonist, exploiting a critical nutritional pathway of the Eimeria parasite. The drug's mechanism is defined by a cascade of molecular events that leads to the specific arrest of parasitic replication.

Competitive Blockade of Parasite Thiamine Uptake

The active compound, Amprolium, is a structural analogue of Thiamine (Vitamin B₁) and acts as a competitive antagonist by binding to the parasite's specialized thiamine transporters with high affinity. This key interaction physically blocks the cellular salvage of the essential nutrient, initiating an immediate state of molecular competition at the parasite's membrane.

Disruption of Energy and Replication Pathways

By preventing Thiamine uptake, the drug induces an intracellular deficiency of the active cofactor, Thiamine Pyrophosphate (TPP), which is vital for the parasite’s carbohydrate metabolism. This metabolic shutdown is effective against the rapidly dividing first-generation schizonts, as their high energy demands cannot be met, leading to the inhibition of the asexual reproductive cycle.

Mechanism of Selective Toxicity

Amprolium achieves selective toxicity because its binding affinity for the parasite’s thiamine transporters is substantially greater than its affinity for the host animal’s transporters. This kinetic difference ensures that the required concentration effectively starves the parasite and arrests its growth while minimizing metabolic interference in the host, which establishes the drug's physiological basis of action. The cascade of molecular events results in the inhibition of the Eimeria parasite's life cycle progression within the host's intestinal tract.

Dosage and Administration Information

How Amprosid is Used: Administration Guidelines

Amprosid (Amprolium) is administered via the oral route, primarily delivered on a mass scale by incorporating the medicine into the animal's drinking water or feed. The usage is characterized by defined doses, specific concentrations, and set course durations.

Target Population Dosing Regimen Duration Pattern
Calves (Treatment) 10 mg per kg body weight daily. 5 consecutive days.
Calves (Prevention) 5 mg per kg body weight daily. 21 consecutive days.
Poultry (Treatment) 0.012% concentration in drinking water, or 0.024% for severe outbreaks. 3 to 5 days, followed by a reduced-dose continuation phase.

The medicine is supplied as a 9.6% Oral Solution or a Soluble Powder and is administered daily over the defined course. A key administration principle involves the medicated source (water or feed) being the sole source of consumption for the animal population throughout the treatment period to ensure consistent dosing. The solution is prepared daily with fresh water; however, stock solutions may be held for up to 3 days. For calves, administration protocols involve a herd-basis approach, where the entire exposed group is managed simultaneously, and there are restrictions on use for calves intended for veal.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amprosid


Evidence for Use in Poultry (Chickens, Turkeys, and Laying Hens)

Research exploring Amprosid's active ingredient, Amprolium, has primarily evaluated its application in poultry populations, including broiler chickens, growing chickens, and turkeys. Studies have monitored animals that were experimentally challenged with the parasite and those naturally exposed to the conditions associated with acute or disruptive episodes.

The evidence base consists of controlled floor pen trials and comparative field studies. These studies monitored several key measurements, including the level of parasite output (oocyst shedding) in the animals’ feces, intestinal lesion scores, and overall physical development. Studies reported measurements of intestinal lesions and parasite shedding that were lower in groups receiving Amprolium compared to untreated control groups.

Evidence for Use in Calves (Beef and Dairy)

Research was evaluated in young beef and dairy calves, typically under six months old, to was studied for its application in coccidiosis caused by species such as Eimeria bovis and Eimeria zurnii. The research mainly consists of comparative efficacy studies and field trials conducted with naturally infected animals.

These studies research examined how parasite levels in the feces evolved over defined time intervals, tracking the animals' outcomes related to systemic or functional imbalance, such as the presence and severity of diarrhea. Trials also was studied for effects on the animals' physical development, focusing on weight gain and production metrics.


Studies on Long-Term Outcomes and Durability of Effect

Research has explored outcomes monitored during periods of increased symptom activity and short-term recovery. The duration of follow-up in most efficacy studies follow-up durations were limited, typically focusing on the acute treatment phase (around five to seven days) and immediate post-treatment growth monitoring. Long-term effects are not fully established regarding the sustained control of the parasite burden.


Areas of Uncertainty and Remaining Research Gaps

Despite decades of research, several aspects are still emerging or uncertain in the evidence landscape for Amprolium.

Comparative evidence is lacking for many other compounds in certain populations. One key area of uncertainty is the precise and universal prevalence of drug-resistant parasite strains. While resistance was observed in some studies, the extent of this issue and its impact on performance may vary significantly. As noted, there is limited information for long-term outcomes regarding the sustained absence of parasite shedding.

Key Studies & References

  1. NADA 138-074: Amprolium Soluble Powder - Freedom of Information Summary

Frequently Asked Questions (FAQ)

Common questions about Amprosid (FAQ)


Q: How long does the effect of one Amprosid dose last?

Official veterinary product information suggests that after an animal takes the medicine orally, the absorption into the bloodstream is low. The concentration in the blood typically reaches its maximum level, known as Tmax, approximately four hours after a dose is administered. The required daily administration in water or feed is necessary to maintain the therapeutic concentration over the full course of treatment.


Q: How long before an operation should I stop taking Amprosid?

The required withdrawal period is a critical regulatory safety measure before an animal can be processed for meat, ensuring no drug residue is present in the food supply. This specific period varies based on the species being treated and the specific drug formulation used. For instance, regulatory documents specify a withdrawal time of 3 days for certain poultry and cattle uses, but a longer period may apply to others. Always follow the specific withdrawal period noted on the label.


Q: Does Amprosid need to be taken with food?

The administration of Amprosid is designed to be highly controlled for the animal populations it treats. Official instructions require that the medicine be given as the sole source of drinking water or be thoroughly mixed into the animal's feed throughout the entire treatment period. This method ensures consistent, measured consumption of the medication.


Q: What is the average duration of treatment with Amprosid?

The treatment protocols are precisely defined in the official guidelines depending on the animal and the goal of the treatment. For managing an active condition, the course typically ranges from 3 to 5 consecutive days. For prevention protocols during periods of high risk, the required course duration can be as long as 21 consecutive days.


Q: Does Amprosid interact with alcohol?

The official regulatory documentation for this veterinary medicine lists known interactions only with specific substances, primarily Vitamin B-complex products and bentonite when administered in feed. There are no documented interaction warnings regarding alcohol use in these official product labels.


Q: Does Amprosid cause drowsiness or make you sleepy?

According to the official product information, adverse reactions are generally not known when the drug is used correctly within the approved dose range. While the most serious risk from misuse (Thiamine Deficiency) can cause severe neurological symptoms like incoordination and tremors, simple drowsiness or sleepiness is not typically listed as a side effect.


Q: Can I take Amprosid with my usual morning coffee?

Amprosid is strictly classified as a veterinary medicine intended only for use in approved animal populations. Regulatory agencies do not approve or intend this product for human use or consumption, including taking it with food or beverages like coffee.


Q: Has Amprosid been studied in children?

Amprosid is strictly a veterinary medicine, meaning it is only approved for use in specific animal populations such as poultry and calves. Therefore, there are no official studies or safety data documented by human medical regulatory bodies for its use in human children.


Q: Are there different strengths of Amprosid available?

Yes, the active ingredient, Amprolium, is manufactured in different formulations to allow for mass administration to animal populations. Official product lists show it is available in various concentrations, such as a 9.6% oral liquid solution and a 20% soluble powder.


Q: Can Amprosid affect fertility?

The active ingredient, Amprolium, is chemically classified by some regulatory agencies as a substance suspected of potentially damaging fertility. This classification primarily addresses chemical handling and exposure risks, rather than the approved veterinary use in animals.


Q: What should I do if my symptoms don't improve on Amprosid?

Official product information states that if no improvement is observed within 3 days of starting treatment, the next required step is to have the diagnosis confirmed by a qualified professional, such as a veterinarian or poultry pathologist.


Q: Can I take other vitamins while using Amprosid?

The official label specifically warns against the concurrent use of Amprosid with products containing Vitamin B-complex. Because Amprosid works by mimicking Vitamin B1 (Thiamine), taking Vitamin B-complex products at the same time may reduce the intended efficacy of the medicine.


Q: Does Amprosid help with chronic or acute symptoms?

Official regulatory documents indicate that Amprosid is approved for use in both acute and exposure-related situations. It is formally indicated as an aid in the treatment of an active, acute outbreak and for prevention during periods when animals are at high risk of exposure.


Q: What is the shelf life of Amprosid?

The stability guidelines for this product specify two main timelines. The shelf life for the veterinary product in its original, unopened packaging is typically about two years. However, once the container is opened, the shelf life for the solution may be significantly reduced to as short as six months.


Q: Does Amprosid have a withdrawal period if I stop taking it?

Yes, a mandated withdrawal period is a regulatory safety standard before a treated animal is processed for human food. This period is specified on the label to ensure drug residues clear the animal's system. Depending on the species and usage, it may be zero days for some poultry uses or a specified duration, such as 3 days, for other cattle and poultry applications.

How should Amprosid be stored and disposed of?

Official Storage and Disposal Guidelines

Regulatory information defines strict requirements for storing and disposing of Amprosid/Amprolium products to maintain stability and ensure safety. Storage conditions typically require the product to be kept within a controlled temperature range, such as 5 C to 25 C (41 F to 77 F), and mathbfmust be protected from direct sunlight and freezing.

Storage Constraint Requirement (as per official label)
Container & Safety Keep mathbftightly closed, mathbfin original packaging, and mathbfout of the reach of children.
Stability Limits Use liquid products within mathbf6 months after first opening; diluted solutions often require mathbfrenewal every 12 to 24 hours.

All disposal of unused or expired product and related waste materials must occur mathbfin accordance with local, regional, and national regulations. It is specifically prohibited to release the product or waste into the environment, including public waterways or sewer systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amprosid found in:

A-Z Index: